Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the potential for immune-oncology treatments to treat mesothelioma effectively.

A number of immuno-oncology treatments with the potential to treat mesothelioma are in development.

Most significant new drugs are referred to the National Institute for Health and Care Excellence’s (NICE) technology appraisal programme to assess their clinical and cost effectiveness. Decisions on the suitability of these drugs for NICE appraisal will be made through the established topic selection process.